Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Fig. 1

Expression pattern of NNMT in ovarian cancer tissues. a Differential expression of NNMT between FTs and POCs/PTCs. b Differential expression of NNMT between primary ovarian tumors and matched omental metastases. c Differential expression of NNMT between tumors with recurrence and tumors with no-recurrence. d Differential expression of NNMT between LVSI-positive ovarian cancers and LVSI-negative ovarian cancers

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us